Product category:
Chromatographs: liquid, ion, gel, HPLC
News Release from: ESA Biosciences | Subject: CoulArray
Edited by the Laboratorytalk Editorial
Team on 22 June 2005
Drug levels and metabolic effects
simultaneously
Electrochemical detection technique uses microdialysis perfusion to permit direct sampling of the brains extracellular fluid, within the blood-brain barrier, in freely moving animals
ESA Biosciences has issued an application note describing a methodology, based upon the company's CoulArray electrochemical array detector technology, that is capable of quantifying the central level of a drug while simultaneously measuring its effect on central metabolism The central level of a drug and its effect on neurotransmitter metabolism was, until recently, normally determined in brain tissue homogenates
This article was originally published on Laboratorytalk on 23 Jul 2001 at 8.00am (UK)
Related stories
Simultaneous analysis of vitamins in serum
A new technical note from ESA Analytical describes a validated method for the sample preparation and analysis of fat soluble vitamins in serum
Multi-dimensional HPLC detector
ESA Analytical says the CoulArray II detector is a revolutionary new instrument that works with your HPLC to provide a 3-dimensional look at your sample
However this approach suffers from a number of disadvantages including the inability to accurately examine tissue distribution, the loss of analyte compartmentalisation, and the need for a large number of test animals.
The electrochemical detection technique developed by ESA uses microdialysis perfusion to permit direct sampling of the brains extracellular fluid, within the blood-brain barrier, in freely moving animals.
Based upon an HPLC with coulometric array detection method, applications data is presented using the anti-hypertensive drug H(1-hydrazinophthalazine) as an example of how a drug passes through the blood-brain barrier and can be measured quickly and effectively post infusion.
The data presented clearly demonstrates the potential of coupling in vivo microdialysis to HPLC with coulometric array detection to enable simultaneous measurement of a drug's level and its effects on central monoamine metabolism.
Using ESA's CoulArray Electrochemical detector for HPLC provides the superior sensitivity and selectivity required for measuring low picogram levels of centrally acting drugs and their metabolites in brain extracellular fluid. Request a free brochure from ESA Biosciences ...
• ESA Biosciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
